期刊文献+

维持性血液透析患者乙肝表面抗体水平变化的观察分析 被引量:1

Observation and analysis of the change of hepatitis B surface antibody levels in maintenance hemodialysis patients
暂未订购
导出
摘要 目的动态观察维持性血液透析(HD)患者血清乙型肝炎病毒表面抗体(抗-HBs)滴度水平变化。方法选择34例维持性血液透析患者,进行血清抗-HBs滴度检测,间隔6月后复查,分析前后抗体滴度水平的差异。结果34例患者中有28例观察前后的抗-HBs滴度降低,占82.4%;有6例抗-HBs滴度升高,占17.6%。抗-HBs滴度总体水平呈下降趋势,前后有显著差异(P<0.01)。结论维持性血液透析患者血清抗-HBs滴度水平随时间而不断变化,而且降低者所占比例明显高于升高者。 Objective To observe the change of hepatitis B virus surface antibody(anti-HBs) levels in maintenance hemodialysis patients.Methods We evaluated 34 cases of maintenance hemodialysis in this study to test anti-HBs titers before and 6 months after hemodialysis,then analyzed the differences of anti-HBs titers.Results Of 34 patients,anti-HBs titers decreased in 28 patients(82.4%),increased in 6 patients(7.6%).The overall level of anti-HBs titers decreased.There was a significant difference between the before and after titer levels(P0.01).Conclusion Anti-HBs levels in maintenance hemodialysis patients change over time,and the decreased proportion is significantly higher than that elevated.
出处 《临床和实验医学杂志》 2012年第3期170-171,共2页 Journal of Clinical and Experimental Medicine
关键词 血液透析 乙肝病毒表面抗体 滴度水平 Hemodialysis Antibody of the second type hepatitis Titer levels
  • 相关文献

参考文献8

二级参考文献68

  • 1郁佩青,徐琴君.血液透析相关丙型病毒性肝炎的研究进展[J].中华护理杂志,2004,39(8):615-617. 被引量:12
  • 2mIiroga JA,Castillo I,Porres JC,et al.Recombinant gamma-interferon as adjuvant to hepatitis B vaccine in hemodialysis patients[J].Hepatology,1990,12:661-663.
  • 3Donati D,Gastaldi L.Control led trial of thymopentin in hemodialysis patients who fail to respond to hepatitis B vaccina-tion[J].Nephron,1988,50:133-136.
  • 4Meuer SC,Dumann H,Meyer zumBuschenfelde KH,et al.Lowdose interleukin-2 induces systemic immune responses against HBsAg in immunodeficient non-responders to hepatitis B vaccination[J].Lancet,1989,1:15-18.
  • 5Jungers P,Devillier P,Salomon H,et al.Randomised placebo-controlled trial of recombinant interleukin-2 in chronic uraemic patients who ane non-responders to hepatitis B vaccine[J].Lancet,1994,344:856-857.
  • 6Ono K,Kashiwagi S.Complete seroconversion by low-dose intradermal injection of recombinant hepatitis B vaccine in hemodialysis patients[J].Nephron,1991,58:47-51.
  • 7Poux JM,Ranger S,Lagarde C,et al.Efficacy of intrademal injection of recombinant hepatitis B vaccine in dialysis patients[J].Nephrol Dial Transplant,1994,9:1213-1214.
  • 8Marangi AL,Giordano R,Montanaro A,et al.Hepatitis B virus infection in chronic uremia:long-term follow-up of a two-step integrated protocol of vaccination[J].Am J Kidney Dis,1994,23:537-542.
  • 9Vlassopoulos D,Arvanitis D,Lilis D,et al.Low repeated doses of intradermal hepatitis B vaccine produce protective levels of antibodies in hemodialysis patients non-responding to usual and double mul-tiple doses[J].JNephrol,1994,7:340-341.
  • 10Mettang T,Schenk U,Thomas S,et al.Low-dose intradermal versus intramuscular hepatitis B vaccination in patients with end-stage renal failure[J].Nephron,1996,72:192-196.

共引文献73

同被引文献6

  • 1Kayatas M.Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients[J].Artif Organs,2002,26(6):492-496.
  • 2Fabrizi F,Martin P.Met a-a nalysis:the effect of age on immunological response to hepatitis B vaccine in end-stage renal disease[J].Aliment Pharmacol Ther,2004,20(10):1053-1062.
  • 3Dinits-Pensy M,Forrest GN.The use of vaccines in adult patients with renal disease[J].Am J Kidney Dis,2005,46(6):997-1011.
  • 4Cimaz R,Meregalli E.Alterations in the immune system of children from mothers treated with immunosuppressive[J].Toxicol Lett,2004,149(1-3):155-162.
  • 5刘力锋.猪苓多糖联合乙肝疫苗治疗慢性乙型肝炎128例[J].临床医学,2009,29(6):15-16. 被引量:10
  • 6聂红,许周善.复方猪苓多糖对小鼠免疫功能的调节[J].细胞与分子免疫学杂志,2000,16(5):384-386. 被引量:23

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部